JAZZ vs TISI · P/E 1988, rev $2.28B vs rev $228.7M
Jazz Pharmaceuticals PLC (JAZZ) versus Team Inc (TISI) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Team Inc (TISI) is a specialty business services company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported TISI revenue for 2026-06-30 was $228.7M. Net income was -$6.8M. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. TISI currently screens at market cap $77.0M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. TISI currently screens at market cap $77.0M.
Not investment advice. Open the JAZZ and TISI stock pages for the full models.
Not investment advice.